FDA Orange Book

Is there a generic for Ycanth?

Ycanth contains cantharidin. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.

Source: FDA Orange Book data file dated 2026-10-09. Publisher page

No. The Orange Book lists no active FDA-approved generic (ANDA) for Ycanth (cantharidin). The Orange Book shows its last listed patent expires February 19, 2041 and its last listed exclusivity ends July 21, 2028.

Run it in Rivvi

Map Ycanth and your other top fills to their generics

Every strength in RxNorm, with brands that have no generic flagged.

Build the map

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Ycanth products in the Orange Book

Ycanth products and approved generics
Form and routeStrengthBrand statusBrand TEActive genericsGeneric TE codes
solution, topical0.7%Marketed (Rx)None0None

NDA 212905, held by VERRICA PHARMACEUTICALS INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.

Ycanth patents

Patents listed for Ycanth
PatentExpiresCoversUse codeNDA
11052064May 28, 2035Drug productU-3665212905
11052064May 28, 2035Drug productU-3663212905
12233042August 22, 2038Drug productU-3663212905
11147790August 22, 2038Drug productU-3663212905
11147790August 22, 2038Drug productU-3664212905
12290651February 19, 2041Drug productNone212905

Ycanth exclusivity

Exclusivity listed for Ycanth
CodeMeaningExpiresNDA
NCENew chemical entityJuly 21, 2028212905

Ycanth NDC codes

Questions

Is there a generic for Ycanth?

No. The Orange Book lists no active FDA-approved generic (ANDA) for Ycanth (cantharidin). The Orange Book shows its last listed patent expires February 19, 2041 and its last listed exclusivity ends July 21, 2028.

What is the generic name for Ycanth?

The active ingredient in Ycanth is cantharidin, per the FDA Orange Book.

When does the Ycanth patent expire?

The last patent listed for Ycanth in the Orange Book expires February 19, 2041. A listed patent expiry date is not a generic launch date.

What does a therapeutic equivalence code mean?

In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.

More on Ycanth and Cantharidin

Try it on your own data today.

Free to start. Most teams are using it the same day.